Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

Yusuke Nakano; Hirohiko Ando; Wataru Suzuki; Hirofumi Ohashi; Yasushi Suzuki; Hiroaki Takashima; Tetsuya Amano

doi:10.1002/ccr3.4133

Clinical Case Reports (May 2021)

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

Yusuke Nakano,
Hirohiko Ando,
Wataru Suzuki,
Hirofumi Ohashi,
Yasushi Suzuki,
Hiroaki Takashima,
Tetsuya Amano

Affiliations

Yusuke Nakano: Department of Cardiology Aichi Medical University Nagakute Japan
Hirohiko Ando: Department of Cardiology Aichi Medical University Nagakute Japan
Wataru Suzuki: Department of Cardiology Aichi Medical University Nagakute Japan
Hirofumi Ohashi: Department of Cardiology Aichi Medical University Nagakute Japan
Yasushi Suzuki: Department of Cardiology Aichi Medical University Nagakute Japan
Hiroaki Takashima: Department of Cardiology Aichi Medical University Nagakute Japan
Tetsuya Amano: Department of Cardiology Aichi Medical University Nagakute Japan

DOI: https://doi.org/10.1002/ccr3.4133
Journal volume & issue: Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Key Clinical Message In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates understanding the effects of ivabradine in such cases.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords